KCT0002608Recruiting未知
Meditation-based preliminary clinical study for the correlation study between quantitative EEG and 24 hours activity electrocardiogram
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Wonkwang University
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- 19(Year) to 35(Year) (—)
- Sex
- All
Inclusion Criteria
- •1) age over 19 years below 35 years
- •2) Does not indulge in smoking, tea or coffee, has regular diet and a normal sleeping pattern.
- •3) right-handed.
- •4) Were informed of the purpose and process of this clinical trial and voluntarily consented to it.
Exclusion Criteria
- •1) Who has arrhythmia on EKG, or the pulse rate per minute is out of the range of 60-100
- •2) Who has a severe physical illness or medically unstable (Decided by the clinical trial conducter or medical expert.
- •3) Who has a congenital illness, psychological illness , central nervous problem , peripheral nervous problem, endocrinal illness, immunodisease, basal heart disease, liver disease, renal disease.
- •4) Who has a neurological illness such as head trauma or psychological history such as major depressive disorder, anxiety disorder, bipolar disorder, schizophrenia.
- •5) Who has pace maker, stimulation brain devices, ventriculo-peritoneal shunt or artificial organ.
- •6) Who takes medicines that may affect the autonomic nervous system within one week before the enrollment in clinical trials.(example: opiates, stimulants, tricyclic antidepressants, benzodiazepines, and cardiac drugs such as beta-blockers, renin-angiotension-alcosternone system blockers such as angiotensin-converting enzyme inhibiotrs and angiotensin receptor blockers)
- •7)Who smokes, takes alcohol or caffeine contained products since at least 2 hours before the clinical trial.(example: Coffee, coffee milk, Black tea, Green tea, cocoa, coke, chocolate, caffeine contained energy drinks. 8)Who is pregnant or breast feeding
- •9)Who participated in other clinical study for the past one month or is participating in other clinical studies currently.
- •10) Who is difficult to participate in this study judged by investigator.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Study to investigate the effect of AP301 on treatment of primary graft dysfunction (PGD) after primary lung transplantatioEUCTR2013-000716-21-ATApeptico Forschung und Entwicklung GmbH
Recruiting
Phase 1
Clinical trial retreatment by therapeutic vaccine against HBVChronic hepatitis BD019694JPRN-jRCTs061200009Hiasa Yoichi70
Recruiting
Not Applicable
Study on navauppu mezhugu in dysmenorrhoeaCTRI/2017/06/008938Ayothidas pandithar hospital10
Recruiting
Not Applicable
Therapeutic effect of autologous adipose tissue derived stromal vascular fraction to neuropathic pain syndrome; Preliminary reportSymptoms, signs and abnormal clinical and laboratory findings, NECKCT0006517Hanyang University10
Active, not recruiting
Not Applicable
Pilotstudie zur Therapieoptimierungsstudie für den Morbus Hodgkin bei Kindern und JugendlichenPrüfung der Verträglichkeit der ChemotherapiekombinationVECOPA bei Patienten der Therapiegruppen 2 und 3 - GPOH-HD 2002 Pilot / VECOPAPilotstudie zur Therapieoptimierungsstudie für den Morbus Hodgkin bei Kindern und JugendlichenPrüfung der Verträglichkeit der ChemotherapiekombinationVECOPA bei Patienten der Therapiegruppen 2 und 3EUCTR2004-005244-28-DEniversität Leipzig30